1. All Topics
  2. Testimonial
  3. Videos
  4. Virus Research
  5. Product Information

Syringe Pumps

  1. Popular UMP3 Injector is Not Your Ordinary Syringe Pump
    July 13, 2020
    [by Alec Dickson] Easy to Configure Using the SmartTouch Interface The UMP3 UltraMicroPump is easy to configure using the SMARTouch interface. It is pre-programmed for popular microsyringes and allows for user-defined syringe parameters, too. This ensures nearly universal compatibility. You can control up to two pumps, either simultaneously or independently, and the optional foot switch means hands-free operation. You can instantly verify actual injection volume on the graphical display. You can even use the touch screen while wearing gloves. Ensure Reliable Injections of Small Volumes The extremely fine thread-pitch of the UMP3 drive shaft ensures reliable injections
  2. Versatile Microinjection Syringe Pump (UMP3T) for Injections in the Nanoliter to Milliliter Range
    May 15, 2020
    The UltraMicroPump3 is a versatile microinjection syringe pump designed to support the needs of a busy lab. The UMP3 Microinjector is suitable for delivery of media from nanoliters to milliliters. the UMP3 injecotor’s user interface and system design enables delivery of highly accurate and repeatable injections. The choice for thousands of scientists, it is widely cited in research papers.   Intuitive Touchscreen Display for Easy Setup The SMARTouch controller has an intuitive touch screen interface and an easy-to-use menu for quick configuration of the syringe size, volumes and f
  3. Genetic Transfer (viral or non-viral vector) Using Microprocessor-Controlled Injector
    March 02, 2020
    With the first approved human gene therapy trial in 19891 (Rosenberg, et.al.), gene therapy has come a long way in modern medicine and is making inroads in clinics and the market in general.2,3 2017 was an important year for gene therapy when Luxurna, the first human gene therapy drug for an inherited retinal dystrophy, was approved by Food and Drug Administration (USA).4 Now several drugs are undergoing clinical trials. With an estimated $11 billion (USD) market in the next 10 years, both clinical trials and the pharmaceutical industry are expected to benefit immensely from gene therapy.5 With improved use of viral vectors (Adeno-associated virus (AAV), adenovirus, lentivirus, retrovirus, HSV) or non-viral vectors, research and clinical trials on the development of therapeutic genes have witnessed great
┬ęCopyright 2020. World Precision Instruments. All rights reserved.

Apply for Tax Exempt Status
WPI collects tax in AL, AZ, CA, CO, CT, DC, FL, GA, IL, IN, MA, ME, MD, MI, MN, MO, NC, NV, NJ, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA and WI